International Journal of Arrhythmia

Korean Heart Rhythm Society (대한부정맥학회)
권호 표지
DOI QR코드

DOI QR Code

NOAC for Patients with AF and ACS

급성관동맥증후군을 동반한 심방세동 환자에서 NOAC 치료

  • Kim, Dong Hyeok (Division of Cardiology, Department of Internal Medicine, Korea University College of Medicine and Korea University Medical Center) ;
  • Choi, Jong-Il (Division of Cardiology, Department of Internal Medicine, Korea University College of Medicine and Korea University Medical Center)
  • 김동혁 (고려대학교 의과대학 내과학교실) ;
  • 최종일 (고려대학교 의과대학 내과학교실)
  • Received : 2015.12.08
  • Accepted : 2016.03.28
  • Published : 2016.03.31
⟨ Previous Next ⟩

Abstract

Atrial fibrillation (AF) can occur in acute coronary syndrome (ACS), which is a serious medical condition and may require the use of antiplatelet agents in addition to anticoagulants for stroke prevention. Recently, novel or non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly used for stroke prevention in patients with AF instead of traditional OACs. The duration of treatment or treatment with a stepwise approach (e.g. triple, double, or monotherapy) is determined depending on the clinical setting and the balance between the risks of ischemic stroke and bleeding. However, some concerns and controversies in the use of NOACs in patients with AF and ACS need to be addressed. Here, the current management for NOAC therapy in patients with ACS and AF will be reviewed based on recently published guidelines.

Keywords